Coyle, L., Morley, N.J. orcid.org/0000-0002-0497-975X, Rambaldi, A. et al. (6 more authors) (2018) Open-Label, phase 2 study of blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-cell non-hodgkin lymphoma. In: Blood. 60th ASH Annual Meeting, 01-04 Dec 2018, San Diego, CA, USA. American Society of Hematology , p. 400.
Metadata
Item Type: | Proceedings Paper |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2018 by The American Society of Hematology. This is an author-produced version of a paper subsequently published in Blood. Uploaded in accordance with the publisher's self-archiving policy. |
Dates: |
|
Institution: | The University of Sheffield |
Academic Units: | The University of Sheffield > Sheffield Teaching Hospitals |
Depositing User: | Symplectic Sheffield |
Date Deposited: | 23 May 2019 13:50 |
Last Modified: | 21 Nov 2019 01:39 |
Published Version: | http://www.bloodjournal.org/content/132/Suppl_1/40... |
Status: | Published |
Publisher: | American Society of Hematology |
Refereed: | Yes |
Identification Number: | 10.1182/blood-2018-99-112280 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:143614 |